The future of gene therapy in the treatments of urologic malignancies

Urologic Clinics of North America

Volumn 25, Issue 1, 1998, Pages 23-38

  Simons, J W ^a   Marshall, F F ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER THERAPY; DNA DETERMINATION; FUTUROLOGY; GENE TECHNOLOGY; GENE THERAPY; HUMAN; MEDICAL TECHNOLOGY; MOLECULAR BIOLOGY; MOLECULAR GENETICS; PRIORITY JOURNAL; URINARY TRACT CANCER;

EID: 0031939825     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70430-4     Document Type: Article

References (56)

1. W. Anderson Human gene therapy Science 256 1992 808 813
2. S.A. Rosenburg Karnofsky Memorial Lecture. The immunotherapy and gene therapy and gene therapy of cancer J Clin Oncol 10 1992 180 199
3. W.F. Anderson Human gene therapy Science 256 1992 808 813
4. H.V. Aposhian The use of DNA for gene therapy—the need, experimental approach, and implications Perspect Biol Med 14 1970 987 1008
5. W.L. Bi L.M. Parysek R. Warnick In vitro evidence that metabolic cooperation is responsible for the bystander-effect observed with HSV-tk retroviral gene therapy Hum Gene Ther 4 1993 725 731
6. J.R. Bischoff D.H. Kirn A. Williams An adenovirus mutant that replicates selectively in p53-deficient human tumor cells Science 274 1996 373
7. M.A. Carducci S.R. Ayyagari M.G. Sanda Gene therapy for human prostate cancer: Translational research in the hormone refractory dunning prostate cancer model Cancer 75 1 1995 2014 2019
8. B.S. Carter C.M. Ewing W.S. Ward Allelic loss of chromosome 16q and 10q in human prostate cancer Proc Natl Acad Sci USA 87 1990 8751 8755
9. S.H. Chen H.S. Shine J.C. Goodman Gene therapy for brain tumors: regression of experimental gliomas by adenovirus mediated gene transfer in vivo Proc Natl Acad Sci USA 91 1994 3057 3059
10. K.W. Culver R.M. Blaese Gene therapy for cancer TIG 10 5 1994 174 178
11. K.W. Culver Gilder Van C.J. Link Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Th Cancer Res 5 1994 343 379
12. J.T. Dong C.W. Rinker-Schaeffer T. Ichikawa Prostate cancer—biology of metastasis and its clinical implications World J Urol 14 3 1996 182 189
13. G. Dranoff E. Jaffee A. Lazenby Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity Proc Natl Acad Sci USA 90 1993 3539 3543
14. S.E. Ettinghaus S.A. Rosenberg Immunotherapy and gene therapy of cancer Adv Surg 28 1995 223 254
15. E.R. Fearon D.M. Pardoll T. Itaya Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response Cell 60 1990 397 403
16. E.R. Fearon B. Vogestein A genetic model for colorectal tumorigenesis Cell 61 1990 759
17. B. Fisher B.S. Packard E.J. Read Tumor localization of adoptively transferred indium-111 labeled tumor-infiltrating lymphocytes in patients with metastatic melanoma J Clin Oncol 7 1989 250 261
18. S. Freeman C. Abboud K. Whartenby The “bystander” effect: Tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 53 1993 5274 5283
19. S. Freeman J. Zwiebel Gene therapy of cancer Cancer Invest 11 1993 676 688
20. S.J. Hall S.E. Mutchnik S.-H. Chen Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer Int J Cancer 70 1997 183 187
21. W.S. Hsieh J.W. Simons Systemic therapy of prostate cancer. New concepts from prostate cancer tumor biology Cancer Treat Rev 19 1993 229 260
22. B.E. Huber Gene therapy strategies for treating neoplastic disease Ann NY Acad Sci 716 1994 6 11
23. J.T. Isaacs Development and characteristics of the available animal model systems for the study of prostatic cancer D.S. Coffey W.A. Gardner W. Bruchovsky Current Concepts and Approaches to the Study of Prostate Cancer 1987 Alan R. Liss New York 513 576
24. J.T. Isaacs W.B. Isaacs W.F.J. Feitz Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers Prostate 9 1986 262 281
25. W.B. Isaacs G.S. Bova R.A. Morton Genetic alterations in prostate cancer Cold Spring Harbor Synopsis on Quantitative Biology 59 1994 653 659
26. E. Jaffee G. Dranoff L. Cohen High efficiency gene transfer into primary human tumor explants without cell selection Cancer Res 53 1993 2221 2226
27. K.W. Kinzler B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
28. S.C. Ko J. Cheon C. Kao Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models Cancer Res 56 1996 4614 4619
29. W.H. Lee R.A. Morton J.I. Epstein Cytidine methylation of regulatory sequences near the π-class glutathione S -transferase gene accompanies human prostatic carcinogenesis Proc Natl Acad Sci USA 91 1994 11733 11737
30. Lim, Rodriguez, Simons: Unpublished observations
31. H. Levitsky A. Lazenby R. Hayashi In vivo priming of 2 distinct antitumor effector populations: The role of MHC class-I expression J Exp Med 179 1994 1215 1224
32. H.I. Levitsky J. Montgomery M. Ahmadzadeh Immunization with GM-CSF-transduced, but not B-7 transduced lymphoma cells primes idiotype specific T cells and generated potent systemic anti-tumor immunity J Immunol 156 1996 3858 3865
33. T.J. Liu W.W. Zhang D.L. Taylor Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus Cancer Res 54 1994 3662 3667
34. B. Moss C. Flexner Vaccinia virus expression vectors Ann Rev Immunol 5 1987 305 324
35. R. Mulligan The basic science of gene therapy Science 260 1993 926 932
36. N. Muzyczka Use of adeno-associated virus as a general transduction vector for mammalian cells Curr Top Microbiol Immunol 158 1992 97 129
37. C.B. Pickett T.H. Rushmore Glutathiones transferases: Structure, regulations, and therapeutic implications J Biol Chem 268 1993 11475 11478
38. Z. Ram S. Walbridge T. Shawker The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats J Neurosurg 81 1994 256 260
39. R. Rodriguez E.E. Schuur H.-Y. Lim A prostate attenuated replication adenovirus (ARCA) CN706: A selective cytotoxic for PSA positive prostate cancer cells Cancer Res 57 1997 2559 2563
40. S.A. Rosenberg The development of new cancer therapies based on the molecular identification of cancer regression antigens Sci Am 1 1995 90 100
41. S.A. Rosenberg B.S. Packard P.M. Aebersold Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma N Engl J Med 319 1988 1676 1680
42. Roth J: Personal communciation
43. J.A. Roth R.J. Cristiano Gene therapy for cancer: What have we done and where are we going J Natl Cancer Inst 89 1 1997 21 39
44. M. Sanda S. Ayyagari E. Jaffee Demonstration of a rational strategy for human prostate cancer gene therapy J Urol 151 1994 622 628
45. M.G. Sanda J.W. Simons Gene therapy for urologic cancer Urology 44 1994 617 624
46. E.R. Schuur G.A. Henderson L.A. Kmetee Prostate-specific antigen expression is regulated by an upstream enhancer J Biol Chem 271 12 1996 7043 7051
47. Simons and Marshall: Unpublished observations
48. J.W. Simons E.M. Jaffee C.E. Weber Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer Cancer Res 57 1997 1537 1546
49. J.R. Smith D. Freije J.D. Carpten Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search Science 274 529 1996 1371 1374
50. W.H. Sweatt J.W. Simons Gene therapy for genitourinary cancer Prin and Prac Genitourinary Onc Chapter 10 1997 121 130
51. S. Taneja A. Gelldegrun K. Dardashti Construction of a prostate specific antigen promoter-driven gene transfer vector: a novel strategy for target specific gene therapy in prostate cancer J Urol 151 1994 491A
52. P. Tolstoshev Gene therapy, concepts, current trials and future directions Annu Rev Pharmacol Toxicol 32 1993 573 596
53. J. Vieweg F. Rosenthal R. Bannerji Immunotherapy for prostate cancer in the Dunning rat model: Use of cytokine gene modified tumor vaccines Cancer Res 54 1994 1760 1765
54. P.E. Werthman K.E. Drazan J.T. Rosenthal Adenoviral-p53 gene transfer to orthotopic and peritoneal murine bladder cancer J Urol 155 1996 753 756
55. J.A. Wolff J. Lederberg An early history of gene transfer and therapy Hum Gene Ther 5 1994 468 480
56. WorldWide Gene Therapy Reports, December, 1996.